MYGN EPS Estimates
Myriad Genetics, Inc.
$4.15
+$0.07(+1.72%)
51
Overall
60
Value
50
Tech
44
Quality
Market Cap
$396.95M
Volume
1.86M
52W Range
$2.74 - $8.59
Target Price
$3.92
MYGN EPS estimates: the consensus estimate for Myriad Genetics, Inc.'s current fiscal year is -$0.99 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
MYGN EPS Estimates
- EPS estimate, current quarter
- $-0.24
- EPS estimate, next quarter
- $-0.26
- EPS estimate, current year
- $-0.99
- EPS estimate, next year
- $-0.93
- EPS growth, 3-year
- -41.64%
| Fiscal year | EPS |
|---|---|
| 2025 | $-3.95 |
| 2024 | $-1.41 |
| 2023 | $-3.18 |
| 2022 | $-1.39 |
| 2021 | $-0.35 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MYGN | $4.15 | +1.7% | 1.86M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |